home / stock / fold / fold quote
Last: | $11.78 |
---|---|
Change Percent: | 0.0% |
Open: | $11.87 |
Close: | $11.78 |
High: | $11.93 |
Low: | $11.485 |
Volume: | 2,475,945 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$11.78 | $11.87 | $11.78 | $11.93 | $11.485 | 2,475,945 | 03-29-2024 |
$11.78 | $11.87 | $11.78 | $11.93 | $11.485 | 2,464,764 | 03-28-2024 |
$11.86 | $11.51 | $11.86 | $11.87 | $11.325 | 2,526,969 | 03-27-2024 |
$11.43 | $11.54 | $11.43 | $11.74 | $11.32 | 1,946,156 | 03-26-2024 |
$11.54 | $11.55 | $11.54 | $11.6865 | $11.44 | 1,342,915 | 03-25-2024 |
$11.53 | $11.72 | $11.53 | $11.76 | $11.445 | 1,750,589 | 03-22-2024 |
$11.69 | $12.08 | $11.69 | $12.24 | $11.66 | 2,188,404 | 03-21-2024 |
$12 | $11.78 | $12 | $12.01 | $11.62 | 3,008,796 | 03-20-2024 |
$11.84 | $11.58 | $11.84 | $11.935 | $11.53 | 3,871,043 | 03-19-2024 |
$11.58 | $11.47 | $11.58 | $11.84 | $11.38 | 2,330,195 | 03-18-2024 |
$11.48 | $11.49 | $11.48 | $11.72 | $11.365 | 5,488,378 | 03-15-2024 |
$11.54 | $11.71 | $11.54 | $11.79 | $11.42 | 4,508,897 | 03-14-2024 |
$11.81 | $11.73 | $11.81 | $11.91 | $11.66 | 6,375,626 | 03-13-2024 |
$11.79 | $12.13 | $11.79 | $12.18 | $11.705 | 3,779,037 | 03-12-2024 |
$12.13 | $12.32 | $12.13 | $12.44 | $12 | 1,657,961 | 03-11-2024 |
$12.3 | $12.5 | $12.3 | $12.61 | $12.145 | 4,714,399 | 03-08-2024 |
$12.29 | $12.66 | $12.29 | $12.76 | $12.26 | 5,597,635 | 03-07-2024 |
$12.6 | $13.49 | $12.6 | $13.49 | $12.365 | 3,755,164 | 03-06-2024 |
$13.35 | $13.4 | $13.35 | $13.53 | $13.185 | 2,072,621 | 03-05-2024 |
$13.46 | $13.29 | $13.46 | $13.49 | $12.99 | 1,781,425 | 03-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Amicus Therapeutics Inc. Company Name:
FOLD Stock Symbol:
NASDAQ Market:
Amicus Therapeutics Inc. Website:
PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today issued its fourth annual Environmental, Social, and Governance (ESG) repo...
PRINCETON, N.J., March 01, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (NASDAQ:FOLD) today announced that management will participate in upcomi...
PRINCETON, N.J., March 01, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in March. Cowen 44th Annual Health Care Conference in Boston, MA, on Monday, March 4, 2024,...